Target RWE Acquires NoviSci, Gains Amgen Investment
Target RWE, a clinical data company based in Durham, didn’t have to go far to find a strategic partner to boost its analytical prowess. The company has acquired NoviSci, a software analysis and services company located in downtown Durham, seven miles away.
Biotech giant Amgen is doubling down on a Durham health data startup with ties to Duke
Amgen, one of the largest biotechnology companies in the world, is doubling down on its investment into a Durham health data startup called NoviSci. NoviSci, founded by two Duke University professors, builds statistical software that companies use to evaluate the effectiveness of drugs in patients.
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Genentech, a member of the Roche Group, will apply Ribometrix’s discovery platform to discover, develop, and commercialize small molecule drug candidates against RNA targets, through a collaboration that could generate more than $1 billion for the Durham, NC-based developer of RNA-based small molecule therapeutics.
410 Medical Awarded FDA 510k Clearance for LifeFlow PLUS
Durham startup 410 Medical has received U.S. Food and Drug Administration (FDA) 510(k) Clearance for its LifeFlow PLUS Blood and Fluid Infuser (LifeFlow PLUS).
Categories: 410 Medical
National Academy of Engineering Recognizes Ligler With Leadership Award
Frances S. Ligler, Ross Lampe Distinguished Professor in the UNC/NC State Joint Department of Biomedical Engineering, has been recognized by the National Academy of Engineering (NAE) with its Simon Ramo Founders Award.
Categories: Advisory Board News